These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24635517)

  • 1. The ChEMBL database: a taster for medicinal chemists.
    Papadatos G; Overington JP
    Future Med Chem; 2014 Mar; 6(4):361-4. PubMed ID: 24635517
    [No Abstract]   [Full Text] [Related]  

  • 2. Computational Method for the Systematic Identification of Analog Series and Key Compounds Representing Series and Their Biological Activity Profiles.
    Stumpfe D; Dimova D; Bajorath J
    J Med Chem; 2016 Aug; 59(16):7667-76. PubMed ID: 27501131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pK(BHX) database: toward a better understanding of hydrogen-bond basicity for medicinal chemists.
    Laurence C; Brameld KA; Graton J; Le Questel JY; Renault E
    J Med Chem; 2009 Jul; 52(14):4073-86. PubMed ID: 19537797
    [No Abstract]   [Full Text] [Related]  

  • 4. Matched molecular pairs as a medicinal chemistry tool.
    Griffen E; Leach AG; Robb GR; Warner DJ
    J Med Chem; 2011 Nov; 54(22):7739-50. PubMed ID: 21936582
    [No Abstract]   [Full Text] [Related]  

  • 5. Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets.
    Dimova D; Heikamp K; Stumpfe D; Bajorath J
    J Med Chem; 2013 Apr; 56(8):3339-45. PubMed ID: 23527828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Playbooks of Medicinal Chemistry Design Moves.
    Awale M; Hert J; Guasch L; Riniker S; Kramer C
    J Chem Inf Model; 2021 Feb; 61(2):729-742. PubMed ID: 33522806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do medicinal chemists actually make? A 50-year retrospective.
    Walters WP; Green J; Weiss JR; Murcko MA
    J Med Chem; 2011 Oct; 54(19):6405-16. PubMed ID: 21755928
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
    Lajiness MS; Maggiora GM; Shanmugasundaram V
    J Med Chem; 2004 Sep; 47(20):4891-6. PubMed ID: 15369393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale similarity search profiling of ChEMBL compound data sets.
    Heikamp K; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1831-9. PubMed ID: 21728295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of electronic reaction databases in process chemistry.
    Gange DM; D'Antuono J
    Curr Opin Drug Discov Devel; 2003 May; 6(3):362-9. PubMed ID: 12833669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the discovery of protein kinase inhibitors from the urea class.
    Dumas J; Smith RA; Lowinger TB
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):600-16. PubMed ID: 15503863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New principles in medicinal organometallic chemistry.
    Schatzschneider U; Metzler-Nolte N
    Angew Chem Int Ed Engl; 2006 Feb; 45(10):1504-7. PubMed ID: 16453361
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicinal chemistry in the era of big data.
    Richter L; Ecker GF
    Drug Discov Today Technol; 2015 Jul; 14():37-41. PubMed ID: 26194586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.
    Copeland RA
    Methods Biochem Anal; 2005; 46():1-265. PubMed ID: 16350889
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDB.
    Bournez C; Carles F; Peyrat G; Aci-Sèche S; Bourg S; Meyer C; Bonnet P
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32679723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matched molecular pair analysis: significance and the impact of experimental uncertainty.
    Kramer C; Fuchs JE; Whitebread S; Gedeck P; Liedl KR
    J Med Chem; 2014 May; 57(9):3786-802. PubMed ID: 24738976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
    Bonnet P
    Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors.
    Choi H; Park HJ; Shin JC; Ko HS; Lee JK; Lee S; Park H; Hong S
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2195-9. PubMed ID: 22342625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry tools: making sense of HTS data.
    Kolossov E; Lemon A
    Eur J Med Chem; 2006 Feb; 41(2):166-75. PubMed ID: 16368163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.